OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
33
Results
Show all
Save search
Copy query
Show results for
Unknown
(32)
Proteomics
(1)
Organisms
Homo sapiens
(1)
Repository
pride
(1)
Tissue
Peripheral blood mononuclear cell
(1)
Disease
Chronic lymphocytic leukemia
(1)
Technology Type
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2021
(1)
Release Date
2023
(5)
2024
(4)
2021
(4)
2016
(3)
2015
(3)
2022
(2)
2017
(2)
2014
(2)
2026
(1)
2025
(1)
2020
(1)
2019
(1)
2018
(1)
2013
(1)
2012
(1)
Lab affiliation
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).
Not available
S-EPMC4839072
|
biostudies-literature
Cite
The role of whole brain radiation in primary CNS lymphoma.
Not available
S-EPMC4968379
|
biostudies-literature
Cite
Treatment Regimens for Immunocompetent Elderly Patients with Primary Central Nervous System Lymphoma: A Scoping Review.
Not available
S-EPMC8428349
|
biostudies-literature
Cite
High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.
Not available
S-EPMC7391148
|
biostudies-literature
Cite
Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer.
Not available
S-EPMC4578090
|
biostudies-literature
Cite
Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature.
Not available
S-EPMC3503684
|
biostudies-literature
Cite
Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma.
Not available
S-EPMC9464101
|
biostudies-literature
Cite
The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.
Not available
S-EPMC12896398
|
biostudies-literature
Cite
TGFB1 is secreted through an unconventional pathway dependent on the autophagic machinery and cytoskeletal regulators.
Not available
S-EPMC5915026
|
biostudies-literature
Cite
Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study.
Not available
S-EPMC7981320
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
